Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam besylate with sevoflurane vs propofol for hysteroscopic surgery anesthesia
ChiCTR2400083891Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Anesthesia-related recovery impairment (ARRI) (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Postoperative anesthesia recovery time. Planned start May 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Anesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on ChiCTR2400083891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083891.